Skip to main content

Table 6 Specific toxicities, evaluated by cycles (total 284 cycles)

From: Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study

Toxicity

Grade 1

Grade 2

Grade 3

Grade 4

Total

 

n

%

n

%

n

%

n

%

n

%

Leukopenia

7

(2 %)

18

(6 %)

19

(7 %)

5

(2 %)

49

(17 %)

Neutropenia

4

(1 %)

10

(4 %)

27

(10 %)

12

(4 %)

53

(19 %)

Neutropenic fever

1

(0 %)

2

(1 %)

2

(1 %)

0

(0 %)

5

(2 %)

Anemia

26

(9 %)

25

(9 %)

6

(2 %)

3

(1 %)

60

(21 %)

Thrombocytopenia

16

(6 %)

4

(1 %)

3

(1 %)

0

(0 %)

23

(8 %)

Mucositis

11

(4 %)

27

(10 %)

5

(2 %)

0

(0 %)

43

(15 %)

Hand-foot syndrome

39

(14 %)

16

(6 %)

4

(1 %)

0

(0 %)

59

(21 %)

Nausea

22

(8 %)

5

(2 %)

2

(1 %)

0

(0 %)

29

(10 %)

Vomiting

12

(4 %)

9

(3 %)

6

(2 %)

0

(0 %)

27

(10 %)

Anorexia

38

(13 %)

6

(2 %)

4

(1 %)

0

(0 %)

48

(17 %)

Diarrhea

16

(6 %)

6

(2 %)

0

(0 %)

0

(0 %)

22

(8 %)

Alopecia

35

(12 %)

3

(1 %)

0

(0 %)

0

(0 %)

38

(13 %)